Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Glen T. D. Thomson"'
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectiveThe objective of this study is to determine whether restricted cervical mobility in ankylosing spondylitis (AS) is associated with increased fall frequency or fear of falling.MethodsA total of 134 AS patients and 199 age- and gender-matched
Externí odkaz:
https://doaj.org/article/92cc79c3a040481eab72bebc30d78918
Autor:
Glen T D Thomson, In-Ho Song, Stephen Hall, Ricardo Blanco, Filip Van den Bosch, Louis Bessette, Cristiano A. F. Zerbini, Ryan DeMasi, Yihan Li, Roy Fleischmann, Jeffrey Enejosa, Y. Song
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesTo evaluate efficacy and safety of immediate switch from upadacitinib to adalimumab, or vice versa, in patients with rheumatoid arthritis with non-response or incomplete-response to the initial therapy.MethodsSELECT-COMPARE randomised patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa88f0861816f767a2bab1c98ccf4806
https://doi.org/10.1136/annrheumdis-2020-218412
https://doi.org/10.1136/annrheumdis-2020-218412
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:383-391
Background:Assessment of individuals at risk for falling entails comprehensive neurological and vestibular examinations. Chronic limitation in cervical mobility reduces gaze accuracy, potentially impairing navigation through complex visual environmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7025ade90a3693edc5d3c3648754f3a
https://doi.org/10.1017/cjn.2020.186
https://doi.org/10.1017/cjn.2020.186
Autor:
In-Ho Song, Bernard Combe, Y. Song, Karel Pavelka, Alan Friedman, Stephen Hall, Tim Shaw, Paul Emery, Tsutomu Takeuchi, Eduardo Mysler, Glen T. D. Thomson, Andrea Everding
Publikováno v:
Rheumatology. 59
Background Across all phase 3 studies, treatment with upadacitinib (UPA), a JAK1-selective inhibitor, was associated with significantly higher remission (REM) rates, compared to placebo (PBO) or active comparators, in RA patients who were methotrexat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ca205a046aefd63ad2110c7753b6f98
https://doi.org/10.1093/rheumatology/keaa111.195
https://doi.org/10.1093/rheumatology/keaa111.195
Autor:
Sebastian Meerwein, John J. Cush, Glen T. D. Thomson, Casey Schlacher, Kun Chen, Michael E. Weinblatt
Publikováno v:
Poster Presentations.
Background Upadacitinib (UPA), a JAK1-selective inhibitor, demonstrated efficacy in the SELECT-BEYOND study in patients (pts) with moderate to severe rheumatoid arthritis (RA) on a stable dose of csDMARDs who had inadequate response (IR) or intoleran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2183d67ec7e3f510eb1b0f10e75efdb
https://doi.org/10.1136/annrheumdis-2019-eular.3083
https://doi.org/10.1136/annrheumdis-2019-eular.3083
Autor:
Tim Shaw, Bernard Combe, Eduardo Mysler, Alan Friedman, Andrea Everding, In-Ho Song, Y. Song, Karel Pavelka, Stephen Hall, Glen T D Thomson, Paul Emery, Tsutomu Takeuchi
Publikováno v:
Poster Presentations.
Background Across all phase 3 studies, treatment with upadacitinib (UPA), a JAK1-selective inhibitor, was associated with significantly higher remission (REM) rates, compared to placebo (PBO) or active comparators, in RA patients (pts) who were metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d96daac770970afa9ca06b2612b6215
https://doi.org/10.1136/annrheumdis-2019-eular.2003
https://doi.org/10.1136/annrheumdis-2019-eular.2003
Autor:
Roy Fleischmann, Glen T. D. Thomson, LI Yihan, Ricardo Blanco, Ryan DeMasi, J. Enejosa, Cristiano A. F. Zerbini, Stephen Hall, In-Ho Song, Mark C. Genovese, Filip Van den Bosch
Publikováno v:
Oral Presentations.
Background Initiating advanced therapy for rheumatoid arthritis (RA) patients (pts) with a bDMARD or a Janus kinase (JAK) inhibitor is recommended if remission or low disease activity (LDA) is not achieved with csDMARDs.1,2 While data show that pts a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9820af834ff3454b6a6f1fb77408a394
https://doi.org/10.1136/annrheumdis-2019-eular.2886
https://doi.org/10.1136/annrheumdis-2019-eular.2886
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, 2017, 8, pp.23. ⟨10.3389/fneur.2017.00023⟩
Frontiers in Neurology, Frontiers, 2017, 8, pp.23. ⟨10.3389/fneur.2017.00023⟩
Frontiers in Neurology, 2017, 8, pp.23. ⟨10.3389/fneur.2017.00023⟩
Frontiers in Neurology, Frontiers, 2017, 8, pp.23. ⟨10.3389/fneur.2017.00023⟩
International audience; Background: The primate ocular motor system is designed to acquire peripheral targets of interest by coordinating visual, vestibular, and neck muscle activation signals. The vestibulo-ocular reflex (VOR) is greatly reduced at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0774ab59392493ec481e2354f33980af
https://hal.sorbonne-universite.fr/hal-01484357/file/fneur-08-00023.pdf
https://hal.sorbonne-universite.fr/hal-01484357/file/fneur-08-00023.pdf
Autor:
Michel Zummer, Richard J. Cook, Walter P. Maksymowych, Sherry Rohekar, Hua Shen, Glen T. D. Thomson, Bindu Nair, Dafna D. Gladman, Proton Rahman, Renise Ayearst, Robert D. Inman
Publikováno v:
The Journal of Rheumatology. 38:1343-1348
The Spondyloarthritis Research Consortium of Cananda (SPARCC) is a transdiscliplinary research network of investigators interested in spondyloarthritis. The group has been supported by a new research initiative by The Arthritis Society. SPARCC aims t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462c4ddceb08cf373d26312f884b2319
https://doi.org/10.3899/jrheum.101102
https://doi.org/10.3899/jrheum.101102
Autor:
Zoltan Harsanyi, William G. Bensen, André D. Beaulieu, Patricia Quigley, Paul M. Peloso, Glen T. D. Thomson, Boulos Haraoui, Andrew C. Darke, John Eisenhoffer, John Wade
Publikováno v:
Pain Research and Management, Vol 13, Iss 2, Pp 103-110 (2008)
OBJECTIVE: The present study was a randomized, parallel, double-blind comparison between controlled-release (CR) tramadol and sustained-release (SR) diclofenac in patients with chronic pain due to osteoarthritis of the hips and/or knees.METHODS: Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9a6a37de84c80ddf2ff09f134f85b9
https://doaj.org/article/de0f352f721d47bb89361bb06df21988
https://doaj.org/article/de0f352f721d47bb89361bb06df21988